<code id='C5886A58CD'></code><style id='C5886A58CD'></style>
    • <acronym id='C5886A58CD'></acronym>
      <center id='C5886A58CD'><center id='C5886A58CD'><tfoot id='C5886A58CD'></tfoot></center><abbr id='C5886A58CD'><dir id='C5886A58CD'><tfoot id='C5886A58CD'></tfoot><noframes id='C5886A58CD'>

    • <optgroup id='C5886A58CD'><strike id='C5886A58CD'><sup id='C5886A58CD'></sup></strike><code id='C5886A58CD'></code></optgroup>
        1. <b id='C5886A58CD'><label id='C5886A58CD'><select id='C5886A58CD'><dt id='C5886A58CD'><span id='C5886A58CD'></span></dt></select></label></b><u id='C5886A58CD'></u>
          <i id='C5886A58CD'><strike id='C5886A58CD'><tt id='C5886A58CD'><pre id='C5886A58CD'></pre></tt></strike></i>

          knowledge

          knowledge

          author:entertainment    Page View:3378
          A sign of Elevance Health behind some flowers — coverage from STAT
          Michael Conroy/AP

          These days, the surefire way to get ahead in health insurance is to become a health care provider, and Elevance just upped the ante. It’s joining with private equity to launch a $4 billion primary care company.

          Elevance leaders divulged more about the company’s venture with Clayton, Dubilier & Rice on its first quarter earnings call Thursday. The partners announced the new company, yet unnamed, earlier this week, but the release was light on detail. The strategic partnership will house Elevance and CD&R’s doctors, clinics, and the technologies that help those doctors manage their patients.

          advertisement

          Health insurers specialize in managing medical costs, and through ventures like this, they apply that expertise to managing patients’ chronic medical conditions. In arrangements like Medicare Advantage, where insurers are paid set amounts for members’ care, they’re incentivized to keep those patients healthy.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
          Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

          FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

          read more
          Cholera vaccine supply gets boost as demand surges globally
          Cholera vaccine supply gets boost as demand surges globally

          AnurseshowsacholeravaccineinGedaref,Sudan,duringavaccinationcampaign.Anewvaccine,calledEuvichol-S,wi

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          BIO: Crackdown on China pharma industry would threaten U.S. drug supply

          AdobeU.S.legislationthatwouldsevertieswithChinesedrugmakerswouldjeopardizethedrugsupplyformillionsof